For colon cancer that no longer responds to treatment, a new drug combination offers hope: Study Dr. Kamal Kant Kohli27 April 2025 9:30 PM ISTA novel combination therapy offers better outcomes for patients with KRAS G12C metastatic colorectal cancer that have stopped responding to...
Amgen colorectal cancer therapy gets USFDA nod Ruchika Sharma17 Jan 2025 12:29 PM ISTThe Food and Drug Administration has approved Amgen sotorasib (Lumakras) with panitumumab (Vectibix) for adult patients with KRAS G12C-mutated...
Sotorasib Promising for Treating Vascular Malformations Associated with KRAS G12C Mutation: NEJM Medha Baranwal20 July 2024 8:00 AM ISTFrance: A small French study has shown the effectiveness of sotorasib (Lumakras) in treating severe KRAS G12C-related arteriovenous malformations.Two...
Medical Bulletin 23/December/2022 Isra Zaman23 Dec 2022 2:30 PM ISTHere are the top medical news for the day:Sotorasib achieved clinically meaningful activity in KRAS G12C-mutated advanced pancreatic cancerThe KRAS...
Sotorasib achieved clinically meaningful activity in KRAS G12C-mutated advanced pancreatic cancer Isra Zaman23 Dec 2022 9:00 AM ISTThe KRAS protein is part of a normal signaling pathway regulating growth and proliferation of cells, but activating mutations in KRAS drives...
Sotorasib beneficial for certain pancreatic cancers: Study Medha Baranwal29 March 2022 9:00 AM ISTUSA: Sotorasib has shown clinically meaningful anticancer activity and tolerability in heavily pretreated KRASG12C-mutated advanced pancreatic cancer...
Sotorasib safe with durable clinical benefit in lung cancer: NEJM study Dr. Kamal Kant Kohli21 Sept 2020 9:22 PM ISTHOUSTON - Sotorasib has been found to be safe with durable clinical benefit in non-small cell lung cancer (NSCLC) by researchers in an early trial.In...
